These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 3001565

  • 1. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L, Koenig JI, Conway S, McCann SM, Mayfield MA.
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [Abstract] [Full Text] [Related]

  • 2. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L, Koenig JI, Conway S, McCann SM, Mayfield MA.
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 4. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 5. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

  • 6. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG, Stewart BR.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):75-9. PubMed ID: 2996912
    [Abstract] [Full Text] [Related]

  • 7. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.
    Bero LA, Lurie SN, Kuhn CM.
    Brain Res; 1987 Dec 15; 465(1-2):189-96. PubMed ID: 2894234
    [Abstract] [Full Text] [Related]

  • 8. Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat.
    Leadem CA, Yagenova SV.
    Neuroendocrinology; 1987 Feb 15; 45(2):109-17. PubMed ID: 3033534
    [Abstract] [Full Text] [Related]

  • 9. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists.
    Von Voigtlander PF, Lewis RA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Feb 15; 6(4-6):467-70. PubMed ID: 6298890
    [Abstract] [Full Text] [Related]

  • 10. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ, Negus SS, Powell KR.
    Psychopharmacology (Berl); 1991 Feb 15; 103(1):129-35. PubMed ID: 1848712
    [Abstract] [Full Text] [Related]

  • 11. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH.
    Pharmacol Toxicol; 1988 Mar 15; 62(3):150-4. PubMed ID: 2836842
    [Abstract] [Full Text] [Related]

  • 12. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV, Johnson KJ, Proctor WR.
    Br J Pharmacol; 1987 Jul 15; 91(3):523-30. PubMed ID: 3038241
    [Abstract] [Full Text] [Related]

  • 13. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.
    Negus SS, Picker MJ, Dykstra LA.
    Psychopharmacology (Berl); 1990 Jul 15; 102(4):465-73. PubMed ID: 1965748
    [Abstract] [Full Text] [Related]

  • 14. Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats.
    Ramarao P, Bhargava HN.
    Pharmacol Biochem Behav; 1989 Jun 15; 33(2):375-80. PubMed ID: 2554341
    [Abstract] [Full Text] [Related]

  • 15. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
    Kuzmin A, Sandin J, Terenius L, Ogren SO.
    J Pharmacol Exp Ther; 2000 Dec 15; 295(3):1031-42. PubMed ID: 11082438
    [Abstract] [Full Text] [Related]

  • 16. Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat.
    Koenig JI, Mayfield MA, McCann SM, Krulich L.
    Life Sci; 1984 May 07; 34(19):1829-37. PubMed ID: 6330479
    [Abstract] [Full Text] [Related]

  • 17. [Effects of kappa-opiate receptor antagonist MR-2266-BS on ACTH and prolactin release].
    Xu RK, Chen L, Li H, Yang SJ, Huang XY.
    Sheng Li Xue Bao; 1989 Aug 07; 41(4):395-401. PubMed ID: 2557673
    [Abstract] [Full Text] [Related]

  • 18. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1992 Jan 07; 260(1):327-33. PubMed ID: 1309876
    [Abstract] [Full Text] [Related]

  • 19. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ, Członkowski A, Lipkowski A, Herz A.
    J Pharmacol Exp Ther; 1989 Oct 07; 251(1):342-50. PubMed ID: 2571723
    [Abstract] [Full Text] [Related]

  • 20. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
    Bergman J, Warren PH.
    J Pharmacol Exp Ther; 1989 Mar 07; 248(3):1102-8. PubMed ID: 2539457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.